Singapore, April 27 -- TELIX PHARMACEUTICALS (INVESTMENTS) INC. made the following announcement:
Security Name: TELIXPHAR(I)US$600M1.5%N310422
Debt - Listing Confirmation::U.S.$600,000,000 1.50 PER CENT. GUARANTEED SENIOR UNSECURED CONVERTIBLE NOTES DUE 2031 (https://links.sgx.com/1.0.0/corporate-announcements/BCRPOYMUHGGVHHAR/39f2919e0e7989980631e4d1b49c9920762507188a6362508edef2e2051d6f97)
Published by HT Digital Content Services with permission from Health Daily Digest....